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We have identified and characterized a novel intracellular DNA replicative intermediate that is synthesized by heron
hepatitis B virus (HHBV) and not by other avian hepadnaviruses. The new DNA form is synthesized in all host cells tested.
The HHBV nucleic acid template, and not HHBV proteins, is responsible for the formation of the new form. The new form is
comprised of a full-length minus-strand DNA and an incomplete plus-strand DNA whose 5 ends are mapped to DR2,
predominantly. The 3 ends of its plus-strand are located between nucleotides 946 and 1046. Genetic analysis indicates that
the sequences responsible for the formation of the new form lie between nucleotides 910 and 1364. The endogenous
polymerase activity of capsids isolated from cells converted the new form into RC DNA. Intracellular capsids containing the
new form are secreted inefficiently as virions, in comparison to RC- and DL DNA-containing capsids. Our analysis suggests
that the new form is an incomplete RC DNA molecule that is due to a specific block or pause in the synthesis of plus-strand
DNA. Our analysis also suggests that capsids become competent for efficient secretion sometime after the synthesis of 1500
nucleotides of plus-strand DNA. © 2002 Elsevier Science (USA)
Key Words: hepadnavirus; HHBV; DHBV; reverse transcription; new replicative intermediate; iRC; endogenous polymeraseINTRODUCTION
Hepadnaviruses are a family of DNA viruses that rep-
licate predominantly in the liver of their hosts. Hepatitis B
virus (HBV), the prototype member of the family, causes
liver disease in human (Beasley, 1988). Other family
members include woodchuck hepatitis virus (WHV),
ground squirrel hepatitis virus (GSHV), duck hepatitis B
virus (DHBV), and heron hepatitis B virus (HHBV) (Sum-
mers et al., 1978; Marion et al., 1980; Mason et al., 1980;
Sprengel et al., 1988). These family members and their
hosts have been invaluable models in understanding the
replication and pathogenesis of HBV (Seeger and Ma-
son, 2000).
Hepadnaviruses are enveloped viruses whose small
DNA genomes are encapsidated within an icosahedral
capsid (for a review, see Ganem and Schneider, 2001).
Virions contain one of two types of DNA molecules. The
predominant DNA form is a relaxed circular, partially
duplex species (RC) of 3.0 to 3.3 kb, whose circularity is
maintained by 5 cohesive ends (Fig. 1A) (Sattler and
Robinson, 1979). The minus-strand of RC DNA is genome
length and has the viral P protein covalently linked to its
5 end (Molnar-Kimber et al., 1983). The ends of the
minus-strand DNA are mapped to a small terminal re-
dundancy (named 5r and 3r) (Seeger et al., 1986; Lien et
al., 1987). The 11–12 nt direct repeats (DR1 and DR2) are
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348located near the two ends of the minus-strand DNA,
respectively. The 5 end of the plus strand of RC DNA
bears a capped 18 or 19 nt oligoribonucleotide, which is
annealed to DR2 near the 5 end of the minus-strand
(Molnar-Kimber et al., 1984; Lien et al., 1986). The plus-
strand of RC DNA is usually less than genome length for
the mammalian family members, but for DHBV the ma-
jority of the plus-strand DNA is genome length (Lien et
al., 1987). Following infection of hepatocytes, RC DNA is
converted to covalently closed circular DNA (cccDNA),
which is the template for transcription of all the viral
mRNAs (Summers and Mason, 1982; Tuttleman et al.,
1986). The second type of DNA that can be found in
virions is a duplex linear form (DL) (Fig. 1A). Its minus-
strand has the same structure as that of RC DNA. The
plus-strand of DL DNA initiates from DR1 which is at the
3 end of the minus-strand (Staprans et al., 1991). The
function of DL DNA if any in the viral life cycle is un-
known. However, it has been shown that DL DNA-con-
taining virions can initiate an infection through the pro-
duction of cccDNA by nonhomologous recombination
(Yang et al., 1996; Yang et al., 1998).
Hepadnaviruses replicate their genomes via reverse
transcription of a RNA intermediate, the pregenome (for
a review, see Ganem and Schneider, 2001). Reverse
transcription takes place in cytoplasmic nucleocapsids.
Like retroviruses, template switches must occur during
hepadnavirus reverse transcription for replication of the
genome. Synthesis of RC DNA requires three templateactivity; virion secretion.
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© 2002 Elsevier Science (USA)switches: one during the synthesis of minus-strand DNA,
and two during plus-strand DNA synthesis (Staprans et
al., 1991; Wang and Seeger, 1993; Tavis et al., 1994; Loeb
et al., 1997). DL DNA is made when plus-strand synthesis
initiates from DR1 instead of DR2 (Staprans et al., 1991).
Therefore, synthesis of DL DNA involves only the minus-
strand template switch, and no plus-strand template
switches. When DHBV replicative intermediates from cy-
toplasmic capsids expressed by transfection are ana-
lyzed by Southern blotting, three major DNA forms are
synthesized in characteristic proportions (Fig. 1B). Two of
the forms are RC and DL DNA. The third DNA form,
single-stranded DNA (SS) is a full-length minus-strand
DNA. It is not known whether SS DNA from wild type
DHBV is associated with plus-strand DNA.
Heron hepatitis B virus and DHBV are similar in terms
of the morphology of their virions, their genome sizes,
and genome organizations (Sprengel et al., 1988). HHBV
and DHBV share 79% nucleotide identity. The DR1 and
DR2 sequences are identical, while the r sequence is
one nucleotide less than that of DHBV. The amino acid
sequences of the core and small surface proteins are
well conserved. However, the pre-S domain is highly
divergent from that of DHBV (50% amino acid homol-
ogy) (Sprengel et al., 1988). Despite its similarity to DHBV,
HHBV cannot infect Pekin ducks, a host of DHBV (Spren-
gel et al., 1988). Previous reports indicate that Southern
blotting of HHBV replicative intermediates reveals a
characteristic pattern that is very similar to that of DHBV
(Fig. 1B) (Mueller-Hill and Loeb, 1996).
In this report, we identify an HHBV replicative interme-
diate that has not been described previously. Throughout
this report, it will be called the new form. The new form
was not detected in DHBV or Ross Goose hepatitis B
virus (RGHBV). We show that the new form has a struc-
ture similar to RC DNA, except that its plus-strand DNA
is incomplete. It was elongated into RC DNA by the
endogenous polymerase activity of capsids, suggesting
that it could be a precursor in the synthesis of RC DNA.
The new form was synthesized in all host cells tested.
The HHBV nucleic acid, and not the HHBV proteins, was
responsible for the formation of the new form. The new
form-containing capsids were secreted as enveloped
virions, but less efficiently than either RC- or DL-contain-
ing capsids. Genetic analysis suggested that sequences
from nt 910 to 1364 are required for the synthesis of the
new form in HHBV. Although the biological function is
unknown, the new form could be associated with viral
maturation and envelopment.
RESULTS
A novel DNA replicative intermediate is detected
in HHBV
Southern blotting of DHBV DNA extracted from cyto-
plasmic capsids of transfected LMH cells reveals three
major DNA replicative intermediates: RC, DL, and SS
DNA (Fig. 1B). When cytoplasmic replicative intermedi-
ates of HHBV were isolated and analyzed similarly, three
major DNA forms also were seen (Fig. 1B). But when the
same HHBV replicative intermediates were analyzed on
an agarose gel at a lower concentration (0.84% instead of
1.25%), a fourth DNA form was observed (Fig. 2A). We
refer to this fourth form as the new form (NF). The new
form migrated between DL and SS on the 0.84% agarose/
TBE gel, but it comigrated with DL on 1.25% agarose/TBE
gel, suggesting though not proving a circular conforma-
tion for the new form. The new form accumulated to
higher levels than DL DNA and consistently was found at
20% of the level of RC DNA. Southern blotting with
strand-specific probes indicated that the new form con-
tained both minus-strand and plus-strand DNA (Fig. 2B).
When analyzed on a 0.84% agarose gel, the new form
FIG. 1. (A) The structures of RC and DL DNA of DHBV and HHBV. The
P protein (oval) is linked covalently to the 5 end of the minus-strand
(thick black line). The positions of DR1 and DR2 on the minus-strand
DNA are represented as open boxes. The positions of “r” at both ends
of the minus-strand DNA are indicated. The capped oligoribonucleotide
(dotted line and dotted box) at the 5 end of the plus-strand DNA
(hatched line) is generated by the final RNase H cleavage at the
completion of the minus-strand DNA synthesis. It is the primer for
plus-strand DNA synthesis. In DL DNA, the RNA primer initiates plus-
strand synthesis from the 3 end of the minus-strand DNA. In RC DNA,
this RNA primer initiates plus-strand synthesis from DR2, which is near
the 5 end of the minus-strand DNA, due to a template switch called
primer translocation. In RC DNA, the genome is circularized by a
second template switch, in which the nascent plus-strand DNA
switches templates from 5 r to 3 r of the minus-strand DNA. (B)
Southern blot of DHBV and HHBV replicative intermediates isolated
from transfected LMH cells. The samples were electrophoresed in a
1.25% agarose gel in TBE buffer. Lane 1, wt DHBV. Lane 2, wt HHBV. A
genome-length, minus-strand-specific DHBV or HHBV RNA probe was
used to detect viral DNA, respectively. The positions of RC, DL, and SS
DNA are indicated.
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was not observed in Southern blotting of DHBV or Ross
Goose HBV intracellular replicative intermediates (Fig.
2C and data not shown).
HHBV replication was analyzed in two additional cell
lines, Huh7 and HepG2. After transfection, viral DNA was
isolated from cytoplasmic capsids and examined by
Southern blotting. As shown in Fig. 3, the new form was
seen in the cytoplasmic replicative intermediates iso-
lated from Huh7 and HepG2 cells. We then asked
whether the new form was synthesized in primary duck
hepatocyte cultures. Because HHBV does not infect duck
hepatocytes efficiently, we produced pseudotyped HHBV
virions with DHBV envelope proteins (Ishikawa and Ga-
nem, 1995). Southern blotting of replicative intermediates
isolated from primary hepatocytes infected with the
pseudotyped HHBV showed the presence of the new
form (Fig. 3, lanes 7 and 8). However, the level of the new
form in primary hepatocytes was lower than the levels in
the hepatoma cell lines. Consistent with the previous
result with the three hepatoma cell lines, DHBV did not
synthesize the new form in primary hepatocyte cultures
(data not shown). In summary, these results indicated
that primary hepatocytes and three different hepatoma
cell lines supported the synthesis of the new form.
Therefore, synthesis of the new form is a characteristic
of HHBV.
The HHBV nucleic acid template, and not the HHBV
proteins, is responsible for the accumulation
of the new form
Because the synthesis of the new form was a charac-
teristic of HHBV, we asked which viral component(s) was
responsible for, or contributed to, its formation. The likely
candidates were the HHBV nucleic acid template, the
viral polymerase (P) or core (C) proteins. To evaluate the
role of each of these three viral components, we did an
interspecies complementation analysis. Three HHBV
pregenome variants were used, one deficient for P pro-
tein synthesis, one deficient for C protein synthesis, and
one deficient for synthesis of both proteins. We cotrans-
fected expression plasmids for these HHBV pregenome
variants with expression plasmids for either HHBV P
and/or C proteins or DHBV P and/or C proteins. In a
reciprocal analysis, a similar set of DHBV pregenome
variants was cotransfected with expression plasmids for
the appropriate DHBV proteins or HHBV proteins. Viral
replicative intermediates were isolated from cytoplasmic
capsids from LMH cells and examined by Southern blot-
ting. As shown in Fig. 4A, the new form was present in all
of the cotransfections in which the pregenome was de-
rived from HHBV, regardless of the source of the repli-
cation proteins. In addition, the new form was not seen
when DHBV pregenome variants were replicated with
HHBV proteins (Fig. 4B). We also found HHBV prege-
nome variants that are deficient for expression of enve-
lope proteins were also able to synthesize the new form
to wild-type levels (data not shown). Therefore, the syn-
thesis of the new form is an intrinsic property of the
HHBV replication template.
The new form contains a full-length minus-strand
DNA and an incomplete plus-strand DNA
In order to determine its molecular structure, we puri-
fied the new form from an agarose gel. As a comparison,
RC DNA from the same viral sample was purified. Earlier
analysis indicated that the new form contained both
minus- and plus-strand DNA (Figs. 2A and B). To esti-
mate the sizes of each strand, the new form was dena-
FIG. 3. HHBV synthesizes the new form in four different host cells.
Cytoplasmic replicative intermediates were isolated from either trans-
fected cells or infected PDHs and electrophoresed in a 0.84% agarose/
TBE gel and analyzed by Southern blotting. HHBV replicative interme-
diates were isolated from transfected LMH (lanes 1 and 2), Huh7 (lanes
3 and 4), and HepG2 (lanes 5 and 6) cells. Lane 7 and 8 are replicative
intermediates from PDHs infected with pseudotyped HHBV viruses.
The pseudotyped viruses were collected from culture fluid of LMH cells
transfected with a wild-type HHBV genome expression plasmid and a
DHBV envelope expression plasmid. A genome-length, minus-strand-
specific HHBV RNA probe was used to detect viral DNA.
FIG. 2. A fourth DNA form is detected in HHBV but not in DHBV by
Southern blotting. (A) Southern blot of the same HHBV replicative
intermediates as in Fig. 1B, lane 2. The samples were electropho-
resed in a 0.84% agarose/TBE gel. Lane 1, wild-type HHBV. Lane 2,
3-kb linear DNA marker. The position of the new form (NF) is
indicated. The blot was hybridized with a genome-length, minus-
strand-specific HHBV RNA probe. (B) The new form contains plus-
strand DNA. Southern blotting of a 0.84% agarose gel. Lane 3,
wild-type HHBV. Lane 4, 3-kb linear DNA marker. The blot was
hybridized with a genome-length, plus-strand-specific HHBV RNA
probe. (C) Southern blot of DHBV replicative intermediates on a
0.84% agarose/TBE gel. Lane 5, wild-type DHBV. Lane 6, DHBV 3-kb
linear DNA marker. The blot was hybridized with a genome-length,
minus-strand-specific DHBV RNA probe.
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tured at 100°C and Southern blotting was performed. As
shown in Fig. 5A, the denatured minus-strand of the new
form comigrated with the denatured minus-strands of the
purified RC DNA and the total unfractionated viral DNA.
This result indicated that the minus-strand of the new
form was genome length. Analysis of the denatured
plus-strand revealed a different picture. The new form’s
plus-strand migrated more rapidly than that of RC DNA
(Fig. 5B). This smaller plus-strand also was observed in
the total unfractionated viral DNA sample. Using heat-
denatured, linear DNA molecular weight markers, we
estimated the size of the plus-strand of the new form to
be approximately 1500 nt (data not shown). Taken to-
gether, these data demonstrate that the new form is a
double-stranded DNA molecule. Its minus-strand is ge-
nome length, while the plus-strand of the new form is
approximately 1500 nt, which is less than full length.
The 5 end of the minus-strand of the new form is
mapped to nt 2542, while the 5 end of the plus-
strand is mapped mainly to DR2
We next determined the positions of the 5 termini for
each DNA strand by primer extension (Staprans et al.,
1991; Havert and Loeb, 1997). We used primers close to
the 5 termini of the minus- and plus-strands of RC DNA.
Primer 1 detects the 5 end of the minus-strand DNA at
the wild-type position, nt 2542. Primer 2 simultaneously
detects 5 ends of the plus-strand DNA at DR2 and DR1,
since primer 2 is 135 nt from DR2 and 86 nt from DR1. We
included the purified RC DNA and total viral DNA in the
analyses. As shown in Fig. 6A, the 5 end of the minus-
strand DNA of the new form was mapped to nt 2542, the
same position as the 5 ends of the RC DNA and the total
viral DNA. Considering that the minus-strand of the new
form is full length (Fig. 5B), we conclude that the minus-
strand has a wild-type structure. Primer extension on the
plus-strand of the new form yielded a strong signal at
DR2, similar to the purified RC and the total DNA (Fig.
6B). Whether a low proportion of ends mapped to DR1
could not be unambiguously determined. In summary,
this result indicated that synthesis of plus-strand DNA of
the new form initiates mainly from DR2, circularizes, and
elongates for at least 135 nt.
The 3 ends of the plus-strand of the new form are
located between nt 946 and 1046
We estimated that the size of the plus-strand of the
new form was approximately 1500 nt (Fig. 5B). Primer
extension mapped the 5 end of this plus-strand mainly
to DR2 (Fig. 6B). Therefore, the 3 end of the new form’s
plus-strand was estimated to be near nt 1000. In order to
test this prediction, we asked whether probes comple-
mentary to the regions around nt 1000 of the plus-strand
could hybridize to the plus-strand of the new form. Ra-
diolabeled oligonucleotides were used as probes in
Southern blotting. Probe 1, which anneals to nt 539 to 558
of HHBV, hybridized with the new form, as well as the RC
and DL DNA (Fig. 7A). Probe 2, which is complementary
to nt 946 to 964, also hybridized with the new form, RC
and DL DNA (Fig. 7B). However, probe 3, which is com-
FIG. 4. The nucleic acid template of HHBV, and not the replication proteins, is responsible for the formation of the new form. (A) LMH cells were
cotransfected with the indicated combinations of HHBV pregenome expression plasmids represented in rectangles and HHBV protein expression
plasmids or DHBV protein expression plasmids represented in ovals. Purified cytoplasmic replicative intermediates were analyzed by Southern
blotting of a 0.84% agarose/TBE gel. A genome-length, minus-strand-specific HHBV RNA probe was used to detect viral DNA. (B) LMH cells were
cotransfected with the indicated combinations of DHBV pregenome expression plasmids represented in rectangles and DHBV protein expression
plasmids or HHBV protein expression plasmids represented in ovals. Cytoplasmic replicative intermediates were analyzed by Southern blotting of a
0.84% agarose/TBE gel. A genome-length, minus-strand-specific DHBV RNA probe was used to detect viral DNA.
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plementary to nt 1030 to 1046, did not detect the new
form but did detect RC and DL DNA (Fig. 7C). The
inability to detect the new form was not due to lack of
sensitivity in the assay because DL DNA which is less
abundant than the new form was detected with probe 3.
In addition, other oligonucleotide probes complementary
to sequence 3 of nt 1046 did not hybridize with the new
form (data not shown). Therefore, the 3 end(s) of the new
form’s plus-strand is between nt 946 and 1046.
Sequences between nt 910 and 1364 are required for
the formation of the new form in HHBV
The interspecies complementation analysis indi-
cated that synthesis of the new form was an intrinsic
feature of the HHBV template (Fig. 4). This finding
suggested that there could be specific sequences
responsible for the formation of the new form. Removal
of these sequences from the genome might result in
the lack of accumulation of the new form. To this end,
we tested a series of 200 nt-deletion variants of the
HHBV pregenome for their ability to support the syn-
thesis of the new form, when P and/or C proteins were
supplied in trans. As summarized in Fig. 8A, all the
variants were able to synthesize viral DNA except
deletions from nt 562 to 761 and from nt 694 to 893. Of
the variants that synthesized DNA, most, but not all,
supported the synthesis of the new form to a level
similar to wild type. Deletion variants from nt 965 to
FIG. 5. The new form contains a full-length minus-strand DNA and an
incomplete plus-strand DNA. To determine the sizes of the minus- and
the plus-strand, the new form was purified from an agarose gel, dena-
tured at 100°C for 5 min, and analyzed by Southern blotting. (A)
Analysis of minus-strand DNA. Lanes 1–4, untreated control. Lanes
5–8, heat-denatured samples. Lanes 1 and 5, total wild-type HHBV
DNA. Lanes 2 and 6, purified RC DNA. Lanes 3 and 7, purified new form
DNA. Lanes 4 and 8, 3.0-kb DNA marker. A genome-length, minus-
strand-specific HHBV RNA probe was used to detect viral DNA. The
position of the denatured minus-strands is indicated with an arrow. (B)
Analysis of plus-strand DNA. Lanes 9–12, untreated control. Lanes
13–16, heat denatured samples. Lanes 9 and 13, total wild-type HHBV
DNA. Lanes 10 and 14, purified RC DNA. Lanes 11 and 15, purified new
form DNA. Lanes 12 and 16, 3.0-kb DNA marker. A genome-length,
plus-strand-specific HHBV RNA probe was used to detect viral DNA.
The positions of the denatured 3-kb DNA and the plus-strand of the
new form are indicated by arrows.
FIG. 6. Primer extension analysis of the new form indicates the 5
end of the minus-strand is at nt 2542 and the 5 end of the plus-strand
is at DR2. (A) Mapping the 5 end of minus-strand DNA with primer 1.
Lane 1, gel-purified RC DNA. Lane 2, gel-purified new form. Lane 3, total
wild-type HHBV. The sequence ladder (lanes 4–7) was derived from
HHBV and was generated with primer 1. The position of the 5 end of
the minus-strand is indicated. (B) Mapping the 5 termini of the plus-
strand DNA with primer 2. Lane 12, gel-purified RC DNA. Lane 13,
gel-purified new form. Lane 14, total wild-type HHBV. The sequence
ladder (lanes 8–11) was derived from HHBV and was generated with
primer 2. The positions of DR2 and DR1 are indicated.
FIG. 7. The 3 ends of the plus-strand of the new form are located
between nt 946 and nt 1046. Wild-type HHBV intracellular replicative
intermediates and the 3-kb DNA marker were electrophoresed in trip-
licate through a 0.84% agarose gel in TBE buffer. The gel was trans-
ferred to a nylon membrane and then cut into three pieces, each
containing a wt HHBV DNA lane and a 3-kb DNA marker lane. Southern
blotting was performed on each gel, using 32P-labeled oligonucleotide
probes to detect the plus-strands. (A) Probe 1 is complementary to nt
539 to 558. (B) Probe 2 is complementary to nt 946 to 964. (C) Probe 3
is complementary to nt 1030 to 1046. Lanes 1, 3, 5, wild-type HHBV
DNA; lanes 2, 4, 6, 3-kb DNA marker.
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1164 did not accumulate the new form. Deletion vari-
ants from nt 832 to 1031 and from 1047 to 1246 syn-
thesized the new form at a level lower than wild type,
while the variant with nt 1164 to 1363 removed accu-
mulated normal levels of the new form DNA. Based on
these deletions variants, we concluded that a deter-
minant is located between nt 832 and 1164. This re-
gion contained the location of the 3 end(s) of the new
form’s plus-strand (Fig. 7). Since deletions that are up-
stream of nt 832 did not support viral DNA replication, we
cannot exclude a role for sequence between nt 626 and
831 in the synthesis of the new form. In addition, we
analyzed several DHBV and HHBV variants that were
substituted with each other’s sequence over this region
(Fig. 8B). When DHBV sequences from nt 800 to 1036
were substituted into the corresponding HHBV se-
quences, the new form was synthesized by this chimeric
virus. However, the new form was not synthesized by an
HHBV variant with sequences from nt 1033 to 1364 re-
placed by the corresponding DHBV sequences. Interest-
ingly, when we substituted HHBV sequences from nt 910
to 1364 into the corresponding DHBV sequences, we
observed a DNA species which migrated at the same
position as the new form of HHBV (Fig. 8C). This species
was not observed in wild-type DHBV. Overall, the dele-
tion and substitution analyses indicated that sequences
within the region from nt 910 to 1364 were necessary and
sufficient for the synthesis of the new form.
FIG. 8. Sequences responsible for the accumulation of the new form lie between nt 910 and 1364. (A) HHBV genome organization in HHBV
expression plasmid (thick black line). The thin black line represents pregenomic RNA. Locations of the C and P proteins are shown as open boxes.
Locations and sizes of deletions mutants are listed. Mutants were made in P and/or PC background since the deleted sequences overlap with
P and/or C open-reading frames. P or P and C protein donors were provided in trans upon transfection of LMH cells. The presence or absence of
the new form in each mutant as detected by Southern analyses is summarized on the far right. N/A; not available. (B) Genome organizations of the
HHBV/DHBV chimeric plasmids. DHBV genome is shown as open box, while HHBV genome is shown as dotted box. The positions of substitutions
are indicated for each mutant. All the chimeric mutants were constructed in DHBV P or HHBV P background. (C) Southern blot of cytoplasmic
replicative intermediates of chimeric viruses from LMH cells. Lane 1, HHBV. Lane 2, KO44. Lane 3, KO45. Lane 4, KO48. Lane 5, DHBV. Lane 6, KO21.
In samples from lanes 1 to 4 the viruses were reverse-transcribed with HHBV P protein, the samples from lanes 5 to 6 were replicated with DHBV
P protein. The blot was probed with both a genome-length, minus-strand-specific DHBV RNA probe, and a genome-length, minus-strand-specific
HHBV RNA probe. The positions of RC, DL, NF, and SS DNA are indicated.
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The new form can be elongated into RC DNA by the
endogenous polymerase reaction
Our analyses indicated that the new form was a par-
tially double-stranded, circular DNA with an incompletely
elongated plus-strand (Fig. 9A). A general feature of all
hepadnaviruses is an endogenous DNA polymerase ac-
tivity associated with their capsids (Kaplan et al., 1973;
Mason et al., 1980). Under the appropriate in vitro con-
ditions, the DNA polymerase (P protein) inside the capsid
can incorporate dNTPs into the genome. We asked
whether the new form could be elongated in the endog-
enous polymerase reaction. The endogenous polymer-
ase reaction was performed on intracellular capsids that
were immunoprecipitated (Koschel et al., 2000) from
transfected LMH cells (Fig. 9B). First we determined
whether the new form could be labeled in the endoge-
nous polymerase reaction. When capsids were incu-
bated with 32P-dCTP, dGTP, dATP but no dTTP for 4 h the
new form was prominently labeled, while RC and DL
DNA were not labeled (Fig. 9B, lane 10). We concluded
that capsids containing the new form could participate in
the endogenous polymerase reaction, and that under the
conditions employed, new form DNA was labeled pref-
erentially over RC and DL DNA. Next, we asked whether
the new form could be elongated into RC DNA. Capsids
were pulsed with 0.066 M 32P-dCTP and 400 M dATP,
dGTP, and dTTP for 30 min. New form DNA was labeled
but two other bands that migrated like SS DNA also were
seen (Fig. 9B, lane 4). Then the reaction was supple-
mented with unlabeled dCTP to 400 M and a chase
was performed for increasing lengths of time. Even after
the shortest chase period (20 min), the new form was not
detected. Instead, two slower migrating DNA bands
were seen (Fig. 9B, lanes 5 to 9). The slowest migrating
DNA species appeared to be RC DNA because it comi-
grated with the RC DNA control (Fig. 9B, lane 3). Another
DNA species appeared to migrate at the position of DL
DNA. The two SS DNA species seen during the pulse
also were seen after the chase. From this analysis we
concluded that the new form was labeled during the
pulse period, and a substantial fraction of it was elon-
gated into RC DNA during the chase, although a species
with the mobility of DL DNA also was produced. It is
unclear whether the DL DNA seen in lanes 5 through 9 of
Fig. 9B is authentic in situ primed DL DNA, or an inter-
mediate in the conversion of the new form into RC DNA,
or due to disruption of the cohesive ends of the RC DNA
during the preparation of DNA after the endogenous
polymerase reaction. The SS DNA seen in lanes 5
through 9 of Fig. 9B is likely the result of the elongation
of single-stranded DNA that was labeled during the
pulse (Fig. 9B, lane 4).
Capsids containing the new form are not efficiently
secreted as virions
Previous reports have shown that capsids containing
immature DNA are secreted very inefficiently as virions
(Summers and Mason, 1982; Gerelsaikhan et al., 1996;
Wei et al., 1996). Therefore, we asked whether capsids
containing the new form were secreted as virions. We
analyzed enveloped HHBV virion DNA from the culture
media of transfected LMH cells. Nonenveloped capsids
in the medium were removed by pronase-DNaseI treat-
ment (Lenhoff and Summers, 1994b). We did not detect
SS DNA-containing capsids as enveloped virions (Fig.
10A), which is consistent with previous reports (Wei et al.,
1996). The new form was observed in the extracellular
virions, which suggested that capsids containing the
new form could be secreted as virions (Fig. 10A). How-
ever, the ratio of new form DNA to RC DNA in the
extracellular virions was more than 10-fold less than the
ratio in the intracellular capsids (Fig. 10B, left chart). As
a comparison, the ratio of DL to RC in the extracellular
FIG. 9. The new form can be elongated into RC DNA in the endog-
enous DNA polymerase reaction. (A) Structure of the new form. The
location of the 3 ends of the plus-strand is indicated. The new form is
similar to RC DNA in structure (Fig. 1A), except that its plus-strand is
1500 nt. (B) Pulse-chase analysis of HHBV capsids with the endoge-
nous DNA polymerase reaction. Cytoplasmic HHBV capsids were im-
munoprecipitated with DHBV anti-core antibody and endogenous poly-
merase reactions were performed as described under Materials and
Methods. The concentration of -32P-dCTP was 0.066 M during the
pulse. The chase involved adding dCTP to a final concentration of 400
M. Lane 1, end-labeled linear DNA markers; Lane 2, same as lane 1
but denatured at 100°C for 5 min. Lane 3, HHBV DNA isolated from
intracellular capsids and labeled in a reaction with AMV reverse tran-
scriptase, -32P-dCTP, dATP, dGTP, but no dTTP. Lanes 4–9, endoge-
nous polymerase reaction, pulse-chase analysis with time of chase
indicated above each lane. Lane 10, endogenous polymerase reaction
with -32P-dCTP (0.066 M), dATP (400 M), dGTP (400 M), but no
dTTP for 4 h. The positions of the 3-kb linear DNA, SS DNA, RC DNA,
and NF DNA are indicated.
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virions was very similar, if not identical, to the ratio in the
intracellular capsids (Fig. 10B, right chart). This result
indicated that DL-containing capsids were secreted as
virions at a similar efficiency as the RC-containing cap-
sids, but capsids containing the new form were not
secreted efficiently as enveloped virions. This analysis
suggested that capsids are secreted efficiently some-
time after the synthesis of 1500 nt of plus-strand DNA.
DISCUSSION
We have identified and characterized a previously un-
described DNA replicative intermediate of HHBV. For
wild-type HHBV this DNA species is a partially double-
stranded circular DNA. The minus-strand DNA of the
new form appears to be full length and normal in struc-
ture, while the plus-strand has its 5 end at DR2, and is
approximately 1500 nt. The new form can be elongated in
vitro by the endogenous polymerase activity associated
with HHBV capsids. Capsids containing the new form
are secreted inefficiently as enveloped virions. Based on
our analysis, we name the new form iRC DNA, for incom-
plete relaxed circular DNA.
Accumulation of the iRC DNA in HHBV appears to be
due to a specific sequence in HHBV that corresponds to
the position of the 3 end of plus-strand DNA. This
sequence is within the Pre-S ORF, which is highly diver-
gent between HHBV and DHBV (Sprengel et al., 1988).
The level of sequence divergence could be one of the
reasons for the accumulation of the new form in HHBV
but not in DHBV. Formation of the iRC DNA could be due
to a specific pause during elongation of the plus-strand
DNA that is the consequence of a structural feature
within the minus-strand template. However, computer-
aided searches for secondary structures within this re-
gion of the HHBV genome have yet to be informative. In
our analysis, the circular structure of the iRC DNA was
determined from wild-type capsids, which synthesize
predominantly RC DNA and very little DL DNA (Habig
and Loeb, 2002). Based on the conclusion that a se-
quence near the 3 end of the plus-strand of the iRC is
responsible for its formation, we expect that to the extent
that a variant HHBV would synthesize higher than normal
levels of DL DNA, a linear version of the new form or iDL
DNA would accumulate.
In the endogenous polymerase reaction, iRC DNA was
elongated and much of it was converted to RC DNA (Fig.
9B). However, we cannot conclude that iRC DNA is an
obligate intermediate in the synthesis of mature plus-
strand DNA in vivo.We cannot rule out the possibility that
within cells, synthesis of RC DNA and iRC DNA proceeds
in independent pathways. One interesting characteristic
of iRC DNA-containing capsids is their inefficient envel-
opment and secretion (Fig. 10). Further study of this
characteristic might provide insights into the maturation
of capsids and their envelopment during the production
of virions. Earlier studies indicated that capsids with
mature DNA preferentially are secreted as virions (Sum-
mers and Mason, 1982; Gerelsaikhan et al., 1996; Wei et
al., 1996). This observation leads to the notion that at
some point during the synthesis of plus-strand DNA,
capsids acquire a new property and become competent
for envelopment and secretion. This new property corre-
lates with the extent of DNA synthesis, but at what point
during the synthesis of DNA capsids acquire this prop-
erty was not clear. RNA- and SS-DNA-containing capsids
are not competent for virion secretion. Our results sug-
gest that capsids require that more than 1500 nt of
plus-strand DNA before they become fully mature and
competent for efficient virion secretion.
It is possible that the mechanism of formation of iRC
DNA is somehow linked to the process of capsids becom-
ing competent to participate in virion envelopment and
FIG. 10. Capsids containing the new form are secreted inefficiently as enveloped virions. (A) Southern blot of DNA isolated from intracellular
capsids and enveloped virions produced by transfected LMH cells. Lanes 1–4, intracellular HHBV. Lanes 5–8, HHBV DNA extracted from enveloped
virions. A genome-length, minus-strand-specific HHBV RNA probe was used to detect viral DNA. (B) Ratios of NF DNA to RC DNA (left chart), and
DL DNA to RC DNA (right chart). The relative amount of RC DNA, DL DNA, and NF DNA for each lane in (A) was quantified with ImageQuant V5.2.
The ratios of RC to NF and RC to DL for each lane were plotted on the histogram. The gray bars represent the intracellular ratios, while the black
bars represent the extracellular ratios.
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secretion. If true, then further study of the capsids contain-
ing the iRC DNAwould lead to a better understanding of the
link between DNA synthesis and virion production.
MATERIALS AND METHODS
Molecular clones
(1) All molecular clones of HHBV are derived from
HHBV strain 4 (Sprengel et al., 1988). Wild-type HHBV
expression plasmid (named 413-2 or H1.4G) contains 1.4
tandem copies of HHBV-4 DNA inserted into an EcoRI
site in the vector pIBI21 (Ishikawa et al., 1995). Details
describing HHBVP, HHBVC, HHBVPC, and the
HHBV protein donor constructs have been reported pre-
viously (Mueller-Hill et al., 1996).
(2) All molecular clones of DHBV are derived from
DHBV strain 3 (Sprengel et al., 1985). Wild-type DHBV
expression plasmid (named D1.5G) contains 1.5 tandem
copies of DHBV3 DNA inserted into BamHI and EcoRI
sites of pBS vector (Ishikawa and Ganem, 1995). Details
describing the DHBVP, DHBVC, DHBVPC, and
DHBV protein donor constructs have been reported pre-
viously (Loeb et al., 1996; Havert and Loeb, 1997).
(3) HHBV deletions 2700–2899, 2880–52, 44–243, 198–
397, and 326–525 were introduced into the parental vec-
tor, KO75. KO75 is a core-minus, polymerase-minus de-
rivative of 413-2. The core-minus mutation of KO75 is a
one nt deletion at 2690 which introduces a premature
termination codon in the core gene, and the polymerase-
minus mutation is the substitution T182A which gener-
ates a premature termination codon in the polymerase
gene. Deletions 2700–2899 and 2880–52 were generated
by overlap extension oligonucleotide-directed mutagen-
esis (Ho et al., 1989). Deletions 44–243, 198–397 and
326–525 were made by oligonucleotide-directed mu-
tagenesis using oligonucleotides with the 200 nt dele-
tions linked to the HindIII (38), EcoNI (398), and AvaI (320)
restriction sites, respectively. HHBV deletions 562–761,
694–893, 832–1031, 965–1164, 1047–1246, 1164–1363,
1270–1469, 1399–1598 were introduced into the parental
vector, KO43. KO43 is a polymerase-minus derivative of
413–2, and KO43 contains the same polymerase-minus
mutation as KO75. Deletion 562–761 was made by over-
lap extension oligonucleotide-directed mutagenesis. De-
letions 694–893, 832–1031, 965–1164, 1047–1246, 1164–
1363, 1270–1469, and 1399–1598 were created by oligo-
nucleotide-directed mutagenesis using oligonucleotides
with the 200 nucleotide deletion linked to the ApaI (693),
SacII (1032), PstI (1165), KpnI (1247), XbaI (1364), SnaBI
(1470), and BstBI (1599) restriction sites, respectively.
Deletions 1476–1675, 1605–1804, 1750–1949, 1857–2056,
1950–2149, 2107–2306, and 2272–2471 reside within the
redundant region of KO43, and therefore, the deletion
mutations were initially subcloned into the vector HJ23,
which contains HHBV sequences from 38 to 3027. Next,
the 5 region of KO43 within the AlwNI (plasmid vector)–
AvrII (403) fragment was cloned into the HJ23 derivatives
containing the 200 nt deletions. Deletions 1476–1675,
1605–1804, 1857–2056, 2107–2306, and 2272–2471 were
created using oligonucleotides with the 200 nucleotide
deletion linked to the SnaBI (1470), BstBI (1599), HpaI
(2057), BstZ17I (2307), and EagI (2472) restriction sites,
respectively. Deletions 1750–1949 and 1950–2149 were
made by overlap extension oligonucleotide-directed mu-
tagenesis. The deletion 427–626 was introduced into the
vector KO41, which is a derivative of KO43 with an engi-
neered PstI site at 421. Deletion 427–626 was cloned
using an oligonucleotide containing the 200 nt deletion
linked to the PstI (421) site.
(4) KO21 contains an HHBV4 substitution generated
by oligonucleotide-directed mutagenesis and cloned into
the parental vector DHBV P. KO44 and KO45 contain
DHBV3 substitutions made by oligonucleotide-directed
mutagenesis and cloned into KO43. KO48 was generated
by cloning the AvrII (403)–XbaI (1364) fragment from 530
to 1 (Mueller-Hill et al., 1996) into KO43.
Cell culture and transfection
Chicken hepatoma cell line LMH was grown in a
mixture of Dulbecco’s modified Eagle’s medium and nu-
trient F-12 medium supplemented with 5% fetal bovine
serum. Human hepatoma cell lines Huh7 and HepG2
were grown in the same medium but supplemented with
10% fetal bovine serum. Transfection was performed by
the calcium phosphate method (Calvert et al., 1994).
Plasmid DNA (10 or 28 g) was transfected into cells
with 50–70% confluence on 60- or 100-mm-diameter
plates, respectively. In cotransfection experiments, the
ratio of protein donor plasmids to recipient plasmids was
1:1. The culture medium containing the calcium phos-
phate-DNA mixture was replaced by fresh medium 16–18
hours posttransfection.
Primary hepatocyte cultures
Primary hepatocytes were isolated from 1-week-old
Pekin ducklings as described previously (Pugh and Sum-
mers, 1989). Cultures were grown in L15 medium sup-
plemented with 5% fetal bovine serum after plating onto
60-mm-diameter plates. Starting from the second day,
the cells were grown in L15 medium with 0.1% glucose,
10 g/ml insulin, 5 g/ml hydrocortisone, and 1% DMSO.
Cells were exposed to viruses for 24 h beginning 2 days
after plating. Medium was changed daily. Cultures were
harvested 10 days postinfection. The plates were
washed once with HEPES-buffered salineEGTA (2 mM
HEPES [pH 7.45], 150 mM NaCl, 0.5 mM EGTA) and
stored at 80°C.
Isolation of viral DNA from transfected cells
1. Isolation of viral replicative intermediates from
transfected cells. Viral replicative intermediates were
isolated from cytoplasmic capsids 3 days posttransfec-
tion as described (Calvert and Summers, 1994).
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2. Isolation of enveloped virion DNA from culture me-
dium. Culture fluid was harvested daily from Day 3 to Day
6 posttransfection. Medium was saved and supple-
mented with Tris (pH 8.0) to 75 mM. Cell debris was
removed by low-speed centrifugation. The clarified me-
dium was stored at 4°C. At Day 6, viral replicative inter-
mediates from cytoplasmic core were isolated as de-
scribed above. For isolation of enveloped viral DNA, 433
l culture fluid was transferred to Eppendorf tubes and
digested with pronase (50 g/ml) at 37°C for 1 h. Non-
enveloped viral DNA was removed by the addition of
DNase I (40 g/ml) and Mg-acetate to a final concentra-
tion of 6 mM and incubated for 30 min at 37°C. Envel-
oped viral DNA was then released by treating the culture
fluid with 10 mM EDTA, 0.4% SDS, 100 mM NaCl, and
pronase (400 g/ml) at 37°C for 1 h. Nucleic acid was
extracted once with equal volumes of phenol/chloroform
(1/1) and once with chloroform. The supernatant was
precipitated with 2.2 vol of ethanol with the addition of 20
g glycogen. The pellet was washed with 70% ethanol,
dried, and resuspended in 15 l of TE.
Concentration of enveloped virus from culture fluid
Concentration of enveloped virus was performed as
described previously (Lenhoff and Summers, 1994a). To
determine the number of genome equivalents in our virus
stock, 400 l of DMEM-F12 medium was added to 10 l
of virus stock and isolation of enveloped viral DNA was
performed as described above. Approximately 108 virus
genome equivalents were used to infect primary duck
hepatocytes on a 60-mm plate.
Isolation of viral replicative intermediates from
primary hepatocytes
Primary hepatocytes were collected 10 days postinfec-
tion. Viral replicative intermediates were analyzed as
previously described (Lenhoff and Summers, 1994b) with
the following modifications. Cells were lysed by 0.9 ml 10
mM Tris (pH 8.0), 1 mM EDTA, 0.2% Nonidet P-40, and the
lysates were clarified by centrifugation at 3000 rpm for 3
min. The supernatants were divided in half into two
Eppendorf tubes, and each tube was treated with 1 l of
Micrococcal Nuclease (Worthington, 22 U/l) in the pres-
ence of 2.5 mM CaCl2 at 37°C for 30 min. The lysates
were then digested by pronase (500 g/ml) in the pres-
ence of 50 mM Tris-HCl, 10 mM EDTA, 0.25% SDS, and
0.1 M NaCl at 37°C for 1 h. Viral nucleic acid was
extracted with phenol and precipitated with ethanol. After
70% ethanol wash and dry, the samples were resus-
pended in 10 l of TE.
Southern blotting analysis
Southern blotting was performed as described (Ha-
vert and Loeb, 1997) on either 0.84 or 1.25% agarose
gels containing 1 Tris-borate-EDTA. A genome-
length, minus-strand-specific, HHBV RNA probe (nt
2583–(3027/1)–2583) was in vitro transcribed by T7
polymerase in the presence of 32P-UTP, and was used
to detect minus-strand DNA. A genome length, plus-
strand-specific, HHBV RNA probe (nt 2583–(3027/1)–
2583) was used to detect plus-strand DNA. To detect
DHBV viral DNA, a genome-length, minus-strand-spe-
cific, DHBV RNA probe (nt 2526–(3021/1)–2526) was
used. Autoradiographic images of Southern blots were
visualized by a Molecular Dynamics STORM. Quanti-
tation was performed using Molecular Dynamics Im-
ageQuant version 5.2.
For hybridization of Southern blots with oligonucleo-
tide probes, 5 pmol of 32P-end labeled probes was used.
Probe 1 contains sequence complementary to HHBV nt
558 to 539. Probe 2 contains sequence complementary
to HHBV nt 964 to 946. Probe 3 contains sequence
complementary to HHBV nt 1046 to 1030. Hybridization
was carried out at 45°C for 3 h in Church hybridization
buffer (7% SDS, 0.5 M Na2HPO4, pH 7.2, 5 mM EDTA,
0.45% BSA). The blots were washed for 5 min with 50 ml
Church wash buffer (1% SDS, 40 mM Na2HPO4, pH 7.2, 1
mM EDTA) at room temperature. Two more washes were
repeated, and followed by the final wash at 45°C for 5
min.
Agarose gel purification of replicative intermediates
and primer extension analysis
HHBV cytoplasmic replicative intermediates were iso-
lated from the transfections of five 100-mm plates, com-
bined, and electrophoresed in a 0.84% agarose/TBE gel
at 35 V for 15 h. The gel was stained with ethidium
bromide and DNA was visualized with UV light. The RC
DNA and new form DNA were excised from the gel and
processed in an Ultrafree-DNA centrifugal filter device
(Millipore, 42600) following the manufacturer’s instruc-
tions. The yield of purified DNA was determined by
Southern blotting. Approximately 500–700 pg of purified
DNA was used in the primer extension analysis. Primer
extension reactions were performed as previously de-
scribed (Staprans et al., 1991; Havert and Loeb, 1997).
Two 32P-end-labeled primers were used in the assay.
Primer 1, derived from HHBV nt 2423 to 2439, was used
to measure the 5 termini of the minus-strand DNA lo-
cated at nt 2542. Primer 2, complementary to HHBV nt
2605 to 2628, was used to measure the 5 termini of the
plus-strand DNA located at DR2 and DR1. The plus-
strand DNA detected at DR2 with primer 2 has circular-
ized and elongated at least 135 nt of plus-strand DNA.
DNA sequencing ladders were generated using a mo-
lecular clone of HHBV as template. Primer extension
products were electrophoresed on 6% polyacrylamide
(7.6 M urea) gel and then dried. Autoradiographic images
of the gel were visualized with a Molecular Dynamics
STORM. Quantitation was performed using Molecular
Dynamics ImageQuant version 5.2.
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Immunoprecipitation of capsids and endogenous
polymerase reactions
Immunoprecipitation of cytoplasmic capsids was car-
ried out as described previously (Koschel et al., 2000)
with the following modifications. Ten milligrams of pro-
tein A-Sepharose CL4B gel was suspended in 600 l of
PBS and preincubated with 5 l of anti-DHBV core anti-
body (a gift from J. Summers) at room temperature for 4 h
with agitation, followed by reducing the suspension vol-
ume to about 50 l. The hydrated protein A gel was then
added to a 0.5 ml lysate from a 60-mm plate of trans-
fected LMH cells that were expressing HHBV, and the
mixture was incubated at 4°C for overnight with agita-
tion. The resin was collected with a brief spin and
washed twice with 1 ml of PBS. Endogenous polymerase
reactions were performed as described previously (Ma-
son et al., 1980; Koschel et al., 2000). Typically, each
reaction contained 50 l of 50 mM Tris-Cl (pH 7.5), 75
mM NH4Cl, 1 mM EDTA, 20 mM MgCl2, 0.1% -mercap-
toethanol, 0.5% Nonidet P-40, 0.4 mM dATP, 0.4 mM
dGTP, 0.4 mM dTTP, 10 Ci of -32P-dCTP (3000 Ci/
mmol), and the protein A beads. The reactions were
carried out at 37°C. After reactions, the beads were
treated with 0.3 mg/ml of proteinase K and 0.05 mg/ml of
tRNA in the presence of 1% SDS, 10 mM Tris-Cl (pH 7.5),
and 10 mM EDTA (final concentrations) at 37°C for 30
min. The mixtures were then extracted once with phenol/
chloroform (1/1). DNA was precipitated with 0.67 M am-
monium acetate and 2.5 vol of ethanol, incubated at
room temperature for 15 min, and spun at room temper-
ature for 15 min. Pellets were dissolved in 100 l of TE.
DNA was precipitated again with 0.67 M ammonium
acetate and 2.5 vol of ethanol as above. The pellets were
resuspended in 10 l of TE. Electrophoresis of the DNA
samples was performed through a 0.84% agarose/TBE
gel at 35 V overnight. The gel was dried and visualized
with a Molecular Dynamics PhosphorImager. For the
pulse-chase labeling, after 30 min pulse-labeling, 0.4
mM unlabeled dCTP was added to each reaction and
incubated at 37°C for 0 min, 20 min, 40 min, 1 h, 2 h, and
4 h. The reactions were terminated by addition of pro-
teinase K-tRNA mixtures (described above).
To prepare a radioactive linear DNA marker, an HHBV
plasmid digested with EagI was end-labeled by AMV
reverse transcriptase in the presence of 0.25 mM dGTP
and 10 Ci -32P-dCTP (6000 Ci/mmol) at 37°C for 15
min. To end-label HHBV replicative intermediates iso-
lated from LMH cells, viral DNA was incubated at 37°C
for 15 min with 0.25 mM dGTP, 0.25 mM dATP, 10 Ci
-32P-dCTP (3000 Ci/mmol), and 24 units of AMV RT.
These reactions were stopped by 2.4 l of 0.5 M EDTA
and passed through a Sephadex G-50 column.
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